These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29058264)

  • 1. SEOM clinical guidelines for anaplastic gliomas (2017).
    Balañá C; Alonso M; Hernandez-Lain A; Hernandez A; Perez-Segura P; Pineda E; Ramos A; Sanchez AR; Teixidor P; Verger E; Benavides M
    Clin Transl Oncol; 2018 Jan; 20(1):16-21. PubMed ID: 29058264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction to: SEOM clinical guidelines for anaplastic gliomas (2017).
    Balañá C; Alonso M; Hernandez-Lain A; Perez-Segura P; Pineda E; Ramos A; Sanchez AR; Teixidor P; Verger E; Benavides M
    Clin Transl Oncol; 2018 Jul; 20(7):937. PubMed ID: 29858734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic glioma: current treatment and management.
    Le Rhun E; Taillibert S; Chamberlain MC
    Expert Rev Neurother; 2015 Jun; 15(6):601-20. PubMed ID: 25936680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
    Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
    Clin Transl Oncol; 2018 Jan; 20(1):3-15. PubMed ID: 29124520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
    Dubbink HJ; Atmodimedjo PN; Kros JM; French PJ; Sanson M; Idbaih A; Wesseling P; Enting R; Spliet W; Tijssen C; Dinjens WN; Gorlia T; van den Bent MJ
    Neuro Oncol; 2016 Mar; 18(3):388-400. PubMed ID: 26354927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of anaplastic glioma.
    Wick W; Wiestler B; Platten M
    Cancer Treat Res; 2015; 163():89-101. PubMed ID: 25468227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.
    Rajmohan KS; Sugur HS; Shwetha SD; Ramesh A; Thennarasu K; Pandey P; Arivazhagan A; Santosh V
    J Clin Pathol; 2016 Aug; 69(8):686-94. PubMed ID: 26743027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide.
    Speirs CK; Simpson JR; Robinson CG; DeWees TA; Tran DD; Linette G; Chicoine MR; Dacey RG; Rich KM; Dowling JL; Leuthardt EC; Zipfel GJ; Kim AH; Huang J
    Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):268-76. PubMed ID: 25636755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022).
    Segura PP; Quintela NV; García MM; Del Barco Berrón S; Sarrió RG; Gómez JG; Castaño AG; Martín LMN; Rubio OG; Losada EP
    Clin Transl Oncol; 2023 Sep; 25(9):2634-2646. PubMed ID: 37540408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Molecular Diagnostics in the Management of Patients with Gliomas.
    Wirsching HG; Weller M
    Curr Treat Options Oncol; 2016 Oct; 17(10):51. PubMed ID: 27501915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular neuro-oncology in clinical practice: a new horizon.
    Weller M; Pfister SM; Wick W; Hegi ME; Reifenberger G; Stupp R
    Lancet Oncol; 2013 Aug; 14(9):e370-9. PubMed ID: 23896276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaplastic gliomas in adults: an update.
    Izquierdo C; Joubert B; Ducray F
    Curr Opin Oncol; 2017 Nov; 29(6):434-442. PubMed ID: 28901965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recursive partitioning analysis of prognostic factors in WHO grade III glioma patients treated with radiotherapy or radiotherapy plus chemotherapy.
    Park CK; Lee SH; Han JH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
    BMC Cancer; 2009 Dec; 9():450. PubMed ID: 20017960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcomes in 1p19q Co-deleted/Partially Deleted Gliomas.
    McNamara MG; Jiang H; Lim-Fat MJ; Sahebjam S; Kiehl TR; Karamchandani J; Coire C; Chung C; Millar BA; Laperriere N; Mason WP
    Can J Neurol Sci; 2017 May; 44(3):288-294. PubMed ID: 28488951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical discussion of the management of anaplastic oligodendroglioma/oligoastrocytoma (both codeleted and nondeleted).
    Anderson MD; Gilbert MR
    J Natl Compr Canc Netw; 2014 May; 12(5):665-72. PubMed ID: 24812135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade and anaplastic oligodendroglioma.
    Van Den Bent MJ; Bromberg JE; Buckner J
    Handb Clin Neurol; 2016; 134():361-80. PubMed ID: 26948366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advances in adults' gliomas biology, imaging and treatment].
    Ducray F; Dutertre G; Ricard D; Gontier E; Idbaih A; Massard C
    Bull Cancer; 2010 Jan; 97(1):17-36. PubMed ID: 20028650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplastic mixed gliomas and anaplastic oligodendroglioma in children: results from the CCG 945 experience.
    Hyder DJ; Sung L; Pollack IF; Gilles FH; Yates AJ; Davis RL; Boyett JM; Finlay JL
    J Neurooncol; 2007 May; 83(1):1-8. PubMed ID: 17252186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thirty years of progress in the management of low-grade gliomas.
    van den Bent MJ
    Rev Neurol (Paris); 2023 Jun; 179(5):425-429. PubMed ID: 37029057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on treatment strategies for anaplastic glioma: a review of literature.
    Simonetti G; Gaviani P; Innocenti A; Botturi A; Lamperti E; Silvani A
    Neurol Sci; 2014 Jul; 35(7):977-81. PubMed ID: 24859855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.